(Total Views: 103)
Posted On: 05/12/2021 1:20:52 PM
Post# of 74550

$BCRX News Article - BioCryst Receives UK Approval of ORLADEYO(TM) (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients https://marketwirenews.com/news-releases/bioc...57301.html


My Twitter: WhyteStocks